BRIEF-Organovo’S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company

Reuters
25 Feb
BRIEF-Organovo’S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company

Feb 25 (Reuters) - Eli Lilly and Co LLY.N:

  • ORGANOVO’S FXR PROGRAM, INCLUDING FXR314, TO BE ACQUIRED BY ELI LILLY AND COMPANY

  • ORGANOVO HOLDINGS INC - TO RECEIVE UPFRONT PAYMENT AND MILESTONES FOR FXR314

  • ORGANOVO HOLDINGS INC - LILLY ACQUIRES ALL COMMERCIAL AND IP RIGHTS TO FXR PROGRAM

Source text: ID:nGNX2v9LqC

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10